3Roehrbom CG,McCannell JD.Etiology,pathophysiology,epidemiology and natural history of benign prostatic hyperplasia In:Walsh PC,Retik AB,Vonghan ED,et al.Campbell's Urology[M].Philadelphia PA:W.B.Sannders Company,2002:1297-330,479-505.
4McConnell JD,Roehrbom CG,Bausfita OM,et al.The long-term effect of doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia[J].N Engl J Med,2003,349:2387-98.
5Hunter DJW,Berra-Unamuno A,Martin-Gordo A.Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older[J].J Urol,1996;155:1965-9.
6AUA Practice Guidelines Committee.AUA guideline on management of benign prostatic hyperplasia (2003).Chapter1:diagnosis and treatment recommendations[J].J Urol,2003 ; 170:530-47.
7Rehman J,Khan SA,Sukkarieh T,et al.Extraperitoneal laparoscopic prostatectomy (Adenomectomy) for obstructing benign prostatic hyperplasia:tranvesical and transcapsular (Millin) techniques[J].J Endourol,2005;19:491-8.
8VeselyS,Knutsan T,DamberJE,et al.Relationship between age,prostare volume,prostate-specific antigen,symptom score and moflowmetry in men with lower urinary tract symptoms[J].Scand J Urol Nephrol,2003 ;37:322-8.
9RoehrbomCG,McConnellJD,Saltzman B,et al.Prescar long-term efficacy and safety study.Storge (irntative) and voiding (obstructive)symptoms as predictors of benign prostatic hyperplasia progression and related outcomes[J].Eur Urol,2002;42:1-6.
10Thomas AW,Abrams P.Lower urinary tract symptoms,benign prostatic obstruction and the overactive bladder[J].BJU Int,2000; 85(Suppl 3):57-68.
